Slideshow

11 Innovations in Psychiatry Resulting From the Pandemic

Author(s):

Suhas Chandran, MD

As we move forward from COVID-19, we take a look at noteworthy achievements that took place at lightning speed to inform response measures in future pandemics.

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
nicotine use
brain schizophrenia
thankful
schizophrenia
birthday celebration
schizophrenia
retirement
exciting, brain
Related Content
FDA Committees Vote to Dismiss Clozapine REMS
November 20th 2024

FDA Committees Vote to Dismiss Clozapine REMS

Heidi Anne Duerr, MPH
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
schizophrenia
November 18th 2024

Long-Acting Injectables and a Team-Driven Approach for Schizophrenia Treatment

Tracy Hicks, DNP, FNP/PMHNP-BC
Teamwork and Trauma: a Conversation With Kasey Grewe, MD, and Niesha Voigt, MD
May 24th 2021

Teamwork and Trauma: a Conversation With Kasey Grewe, MD, and Niesha Voigt, MD

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
failed endpoint
November 11th 2024

Emraclidine for Schizophrenia Fails to Meet Primary Endpoints in Phase 2 EMPOWER Trials

Leah Kuntz
pharmacology
November 7th 2024

Schizophrenia Pharmacology: Version 2.0

John J. Miller, MD
© 2024 MJH Life Sciences

All rights reserved.